Royal Bank of Canada’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-178,062
| Closed | -$15.1M | – | 7326 |
|
|
2019
Q4 | $15.1M | Buy |
178,062
+176,648
| +12,493% | +$11.8M | 0.01% | 1332 |
|
|
2019
Q3 | $71K | Hold |
1,414
| – | – | ﹤0.01% | 4974 |
|
|
2019
Q2 | $51K | Buy |
1,414
+787
| +126% | +$25.7K | ﹤0.01% | 5268 |
|
|
2019
Q1 | $17K | Buy |
627
+425
| +210% | +$10K | ﹤0.01% | 5741 |
|
|
2018
Q4 | $4K | Sell |
202
-990
| -83% | -$23K | ﹤0.01% | 6287 |
|
|
2018
Q3 | $35K | Buy |
1,192
+1,150
| +2,738% | +$43.3K | ﹤0.01% | 5410 |
|
|
2018
Q2 | $1K | Sell |
42
-248
| -86% | -$8.06K | ﹤0.01% | 6437 |
|
|
2018
Q1 | $9K | Sell |
290
-1,054
| -78% | -$32.9K | ﹤0.01% | 5776 |
|
|
2017
Q4 | $37K | Sell |
1,344
-6,454
| -83% | -$199K | ﹤0.01% | 5330 |
|
|
2017
Q3 | $289K | Sell |
7,798
-109,946
| -93% | -$4.05M | ﹤0.01% | 4238 |
|
|
2017
Q2 | $4.48M | Buy |
117,744
+83,882
| +248% | +$3.74M | ﹤0.01% | 2023 |
|
|
2017
Q1 | $1.66M | Sell |
33,862
-16,098
| -32% | -$734K | ﹤0.01% | 2686 |
|
|
2016
Q4 | $1.7M | Buy |
49,960
+16,137
| +48% | +$572K | ﹤0.01% | 2720 |
|
|
2016
Q3 | $1.28M | Sell |
33,823
-3,015
| -8% | -$114K | ﹤0.01% | 2909 |
|
|
2016
Q2 | $1.24M | Sell |
36,838
-1,288
| -3% | -$45.4K | ﹤0.01% | 2928 |
|
|
2016
Q1 | $1.21M | Sell |
38,126
-18,737
| -33% | -$612K | ﹤0.01% | 2885 |
|
|
2015
Q4 | $2.12M | Sell |
56,863
-2,643
| -4% | -$99.9K | ﹤0.01% | 2498 |
|
|
2015
Q3 | $2.26M | Sell |
59,506
-41,437
| -41% | -$1.45M | ﹤0.01% | 2174 |
|
|
2015
Q2 | $2.89M | Sell |
100,943
-2,006
| -2% | -$55.9K | ﹤0.01% | 2019 |
|
|
2015
Q1 | $2.88M | Buy |
102,949
+7,672
| +8% | +$216K | ﹤0.01% | 2008 |
|
|
2014
Q4 | $2.64M | Buy |
95,277
+57,086
| +149% | +$1.41M | ﹤0.01% | 2112 |
|
|
2014
Q3 | $853K | Sell |
38,191
-8,800
| -19% | -$223K | ﹤0.01% | 2971 |
|
|
2014
Q2 | $1.36M | Sell |
46,991
-10,800
| -19% | -$288K | ﹤0.01% | 2573 |
|
|
2014
Q1 | $1.64M | Sell |
57,791
-12,064
| -17% | -$399K | ﹤0.01% | 2384 |
|
|
2013
Q4 | $2.7M | Buy |
69,855
+25,142
| +56% | +$899K | ﹤0.01% | 2070 |
|
|
2013
Q3 | $1.5M | Sell |
44,713
-2,790
| -6% | -$88.9K | ﹤0.01% | 2425 |
|
|
2013
Q2 | $1.46M | Buy |
+47,503
| New | +$1.59M | ﹤0.01% | 2275 |
|
Other funds holding MDCO
Royal Bank of Canada's MDCO Position: Q1 2020 in Review
Royal Bank of Canada sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 178,062 shares — an estimated $15.1M sold.
Royal Bank of Canada first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $15.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Royal Bank of Canada reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Royal Bank of Canada sold 178,062 Medicines Co shares in Q1 2020, an estimated $15.1M.
- Royal Bank of Canada first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Royal Bank of Canada's Medicines Co position peaked at $15.1M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Royal Bank of Canada's 13F filing for Q1 2020, filed 15 May 2020.